SCHEMBL21929166

SCHEMBL21929166

N#Cc1cccc(-c2c(F)cncc2F)c1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 2/20 0.55
▸ CLK4 Q9HAZ1 1/20 0.50
▸ GABRG2 P18507 6/20 0.49
▸ GABRB3 P28472 6/20 0.49
▸ GABRA5 P31644 6/20 0.49
▸ GABRA3 P34903 6/20 0.49
▸ MAOB P27338 1/20 0.47
▸ CYP11B1 P15538 1/20 0.46
▸ CYP11B2 P19099 1/20 0.46
▸ GABRA1 P14867 1/20 0.45
▸ NOTUM Q6P988 1/20 0.44
▸ NPY5R Q15761 1/20 0.44
▸ CHRNB2 P17787 1/20 0.43
▸ CHRNA5 P30532 1/20 0.43
▸ CHRNA4 P43681 1/20 0.43
▸ GRM5 P41594 1/20 0.43
▸ XDH P47989 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22760898 0.84 CLK4 (0.50) IDO1CLK4GABRG2GABRB3GABRA5
SCHEMBL19579268 0.82 GABRG2 (0.51) IDO1CLK4GABRG2GABRB3GABRA5
SCHEMBL24085349 0.82 CLK4 (0.52) IDO1CLK4GABRG2GABRB3GABRA5
SCHEMBL21928506 0.78 CYP11B2 (0.47) CYP11B1CYP11B2NPY5R
SCHEMBL16127479 0.78 CLK4 (0.52) IDO1CLK4GABRG2GABRB3GABRA5
SCHEMBL3172854 0.77 CLK4 (0.56) IDO1CLK4GABRG2GABRB3GABRA5
SCHEMBL22148799 0.76 CLK4 (0.50) IDO1CLK4GABRG2GABRB3GABRA5
SCHEMBL2154026 0.74 CLK4 (0.65) IDO1CLK4GABRG2GABRB3GABRA5
SCHEMBL19579266 0.74 ADRA2C (0.54) IDO1CLK4GABRG2GABRB3GABRA5
SCHEMBL19579116 0.74 ADRA2C (0.54) IDO1CLK4GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 — — US disclosed
EP-3609978-B1 ORGANIC MOLECULES IN PARTICULAR FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2021-03-17 — — EP disclosed
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2020-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200136054-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OGFR, OR51E2 IDO1 602/4885CLK4 3700/4885GABRG2 2297/4885
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA IDO1 1840/4885CLK4 4420/4885GABRG2 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback